(Q37394248)

20 August 2017

Association between duration and type of androgen deprivation therapy and risk of diabetes in men with prostate cancer (English)

1 reference

20 August 2017

1 reference

6

Björn Zethelius

1 reference

20 August 2017

Danielle Crawley

1

0 references

Mieke Van Hemelrijck

object named as

Mieke Van Hemelrijck

series ordinal

9

0 references

Jan Adolfsson

object named as

Jan Adolfsson

series ordinal

8

0 references

Lars Holmberg

series ordinal

7

object named as

Lars Holmberg

1 reference

20 August 2017

2

Hans Garmo

1 reference

20 August 2017

5

Christel Häggström

1 reference

20 August 2017

4

Pär Stattin

1 reference

20 August 2017

3

Sarah Rudman

1 reference

PMCID

5095878

20 August 2017

language of work or name

English

0 references

publication date

25 August 2016

1 reference

International Journal of Cancer

20 August 2017

1 reference

20 August 2017

139

1 reference

20 August 2017

12

1 reference

20 August 2017

2698-2704

1 reference

Cohort Profile Update: The National Prostate Cancer Register of Sweden and Prostate Cancer data Base--a refined prostate cancer trajectory

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5095878

Quantifying the evidence for the risk of metabolic syndrome and its components following androgen deprivation therapy for prostate cancer: a meta-analysis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5095878

Adverse effects of androgen-deprivation therapy in prostate cancer and their management

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5095878

Patterns of androgen deprivation therapies among men diagnosed with localised prostate cancer: a population-based study

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5095878

Cohort Profile: the National Prostate Cancer Register of Sweden and Prostate Cancer data Base Sweden 2.0.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5095878

Absolute and relative risk of cardiovascular disease in men with prostate cancer: results from the Population-Based PCBaSe Sweden

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5095878

Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5095878

Impact of androgen deprivation therapy on cardiovascular disease and diabetes.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5095878

Adipocytokines, obesity, and insulin resistance during combined androgen blockade for prostate cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5095878

The new Swedish Prescribed Drug Register--opportunities for pharmacoepidemiological research and experience from the first six months

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5095878

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5095878

Insulin sensitivity during combined androgen blockade for prostate cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5095878

Changes in body composition during androgen deprivation therapy for prostate cancer

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5095878

The effects of induced hypogonadism on arterial stiffness, body composition, and metabolic parameters in males with prostate cancer

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5095878

Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

2 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FIJC.30403

Comorbidity, Treatment and Mortality: A Population Based Cohort Study of Prostate Cancer in PCBaSe Sweden

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FIJC.30403

Bone loss after initiation of androgen deprivation therapy in patients with prostate cancer

21 January 2018

1 reference

12 December 2020

Changes in bone mineral density and body composition during initial and long-term gonadotropin-releasing hormone agonist treatment for prostate carcinoma

1 reference

12 December 2020

Association between androgen-deprivation therapy and incidence of diabetes among males with prostate cancer

1 reference

12 December 2020

Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer

1 reference

12 December 2020

Identifiers

DOI

10.1002/IJC.30403

1 reference

20 August 2017

1 reference

20 August 2017

1 reference

PMCID

5095878